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ABSTRACT 21 
In papillomavirus infections, the viral genome is established as a double-stranded DNA 22 
episome. To segregate the episomes to daughter cells during mitosis, they are tethered to 23 
cellular chromatin by the viral E2 protein. We previously demonstrated that the E2 proteins of 24 
diverse papillomavirus types, including bovine papillomavirus (BPV) and human papillomavirus 25 
type 16 (HPV16), associate with the cellular DNA helicase ChlR1. This virus-host interaction is 26 
important for the tethering of BPV E2 to mitotic chromatin and the stable maintenance of BPV 27 
episomes. The role of the association between E2 and ChlR1 in the HPV16 life cycle is 28 
unresolved.  Here, we show that the HPV16 E2 mutation Y131A has significantly reduced 29 
binding to ChlR1, but retains transcriptional activation and viral origin-dependent replication 30 
functions.  Subcellular fractionation of keratinocytes expressing E2Y131A shows a marked change 31 
in the localization of the protein. In comparison to wild type E2, the chromatin-bound pool of 32 
E2Y131A is decreased, concomitant with an increase in nuclear matrix-associated protein. Cell 33 
cycle synchronization indicates that the shift in subcellular localization of E2Y131A occurs in mid-S 34 
phase. A similar alteration between the subcellular pools of E2WT protein occurred upon ChlR1 35 
silencing. Notably, in an HPV16 life cycle model in primary human keratinocytes, mutant E2Y131A 36 
genomes were established as episomes, but at a markedly lower copy number than wild type 37 
HPV16 genomes, and were not maintained upon cell passage.  Our studies indicate that ChlR1 is 38 
an important regulator of the chromatin association of E2 and of the establishment and 39 
maintenance of HPV16 episomes.  40 
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IMPORTANCE 41 
Infection with high-risk human papillomavirus (HPV) types is a major cause of anogenital and 42 
oropharyngeal cancers. During infection, the circular DNA HPV genome persists within the 43 
nucleus, independently of the host cell chromatin. Persistence of infection is a risk factor for 44 
cancer development and is partly achieved by the attachment of viral DNA to cellular chromatin 45 
during cell division. The HPV E2 protein plays a critical role in this tethering by simultaneously 46 
binding to the viral genome and chromatin during mitosis. We previously showed that the 47 
cellular DNA helicase ChlR1 is required for the loading of the bovine papillomavirus E2 protein 48 
onto chromatin during DNA synthesis. Here, we have identified a mutation in HPV16 E2 that 49 
abrogates interaction with ChlR1 and show that ChlR1 regulates the chromatin association of 50 
HPV16 E2 and that this virus-host interaction is essential for viral episome maintenance. 51 
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INTRODUCTION 52 
Human papillomaviruses (HPV) are a large family of double stranded DNA viruses that infect 53 
cutaneous and mucosal epithelium causing hyperproliferative lesions, which are at risk of 54 
progressing to anogenital, oropharyngeal and cutaneous cancers. Completion of the HPV life 55 
cycle is absolutely dependent on the terminal differentiation of the infected epithelial cells and 56 
during the productive cycle, the ~8000 base pair viral genome is maintained as 57 
extrachromosomal episomes (reviewed in (1)). Integration of the viral genome into the host 58 
genome is considered a risk factor for cancer progression (2). Therefore, the mechanistic 59 
underpinnings of viral episome establishment during infection and subsequent episomal 60 
maintenance have been the focus of many research studies.  61 
The viral E2 protein plays a complex role in the HPV life cycle. It is essential for viral genome 62 
replication, via a well-studied interaction with the viral helicase E1 (3, 4), and transcriptional 63 
regulation of the viral oncogenes E6 and E7 (5, 6). Additionally, E2 is required for the 64 
segregation of viral genomes into the nuclear compartment of daughter cells during mitotic cell 65 
division, and therefore for episomal maintenance of the viral genomes (reviewed in (7)). E2-66 
mediated viral genome segregation is dependent on virus-virus and virus-host interactions. The 67 
C-terminal DNA-binding domain (DBD) of E2 binds to specific sequences within the viral 68 
genome (8), while during mitosis, the transactivation domain (TAD) can interact with cellular 69 
chromatin by targeting chromatin-bound host cell proteins (9-12), effectively tethering viral 70 
episomes to cellular chromatin as infected cells divide. This tethering mechanism is essential for 71 
viral episome persistence and productive HPV infection (7).  72 
Several cellular proteins have been suggested as the chromatin-associated mitotic receptor for 73 
E2. Interaction with the bromodomain protein, Brd4, is essential for bovine papillomavirus type 74 
1 (BPV1) E2-mediated viral genome tethering (13), but is not essential for chromosomal 75 
attachment of many HPV E2 proteins, including those of the alpha-HPV group (14). It has also 76 
been demonstrated that topoisomerase binding protein 1 (TopBP1) has a role in the chromatin 77 
association of HPV16 E2 during late stages of mitosis and that interaction with TopBP1 78 
regulates the association of E2 with cellular chromatin (15). Interestingly, a mutant of E2 unable 79 
to bind TopBP1 was shown to be transcriptionally competent but unable to support virus 80 
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replication suggesting that the interaction between E2 and TopBP1 is important for episome 81 
establishment (16).  82 
Our previous work identified an interaction between BPV1 E2 and the host cell DNA helicase 83 
ChlR1 and showed that ChlR1 interaction was conserved in HPV types 11 and 16 (17). Following 84 
the identification of a mutant BPV1 E2 protein compromised in ChlR1 binding, we 85 
demonstrated that interaction with ChlR1 is essential for mitotic attachment of BPV1 E2 and 86 
maintenance of BPV1 genomes (17). However, co-localization studies showed that ChlR1 was 87 
not recruited to chromatin-associated E2 foci (17), suggesting that ChlR1 does not function as 88 
the mitotic tether for the E2-viral DNA complex, but rather plays a role in bringing E2 to the 89 
chromatin during DNA replication, prior to mitotic cell division. In support of this hypothesis, 90 
characterization of the interaction between BPV1 E2 and ChlR1 by fluorescence energy 91 
resonance transfer revealed a more robust association during active DNA replication in S phase 92 
of the cell cycle (18). 93 
Following on from these studies, we have now characterized the interaction between HPV16 E2 94 
and ChlR1 and identified a single residue in E2 important for interaction with ChlR1, tyrosine 95 
131. Analysis of a ChlR1 binding defective E2 mutant, E2Y131A, provides evidence that interaction 96 
with ChlR1 is essential for establishment and maintenance of episomal HPV16 infection and 97 
that loss of ChlR1 binding impacts on E2 function by altering chromatin association during S 98 
phase.    99 
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MATERIALS AND METHODS 100 
Plasmids. HPV16 E2 expression plasmid, pCMV-16E2 was a kind gift from Iain Morgan, 101 
University of Virginia, USA and used as a template for site-directed mutagenesis using Pfu Ultra 102 
II HS DNA polymerase (Agilent) to introduce the mutations described in table 1. pCMV-FLAG-103 
ChlR1 expresses N-terminally FLAG-tagged ChlR1 (19) and was obtained from Jill Lahti, St Jude 104 
Children’s, USA, and was used as a template to clone amino acids 1-130 and 63-214 of ChlR1 105 
into NcoI and EcoRI digested pHIS-TEV bacterial expression vector (gifted by Jim Naismith, 106 
University of St Andrews, UK (20)). The E2-dependent transcription reporter p6E2-tk-Luc 107 
encodes six E2 binding sites upstream of a thymidine kinase enhancer and the Firefly luciferase 108 
open reading frame (gifted by Iain Morgan). For viral replication assays, plasmids p16OriM, 109 
which contains the HPV16 origin of replication and pHPV16-HA-E1 which expresses 110 
hemagglutinin (HA)-tagged HPV16 E1 under the control of a CMV promoter were also obtained 111 
from Iain Morgan (21).  112 
The HPV16 114/K genome, cloned into pUC19, was a kind gift from Ethel-Michele de Villiers 113 
(DKFZ, Germany) and used as a template to introduce mutations T3147 to G and A3148 to C to 114 
encode E2 Y131A using Quikchange II XL kit (Agilent Technologies) and primers 5’-115 
gatggagacatatgcaatacaatgcatgctacaaactggacacatatatat-3’ and the reverse complement. 116 
Plasmids extracted from the resulting clones were sequenced throughout the entire HPV 117 
genome to ensure that no other mutations had been introduced. 118 
 119 
Bacterial protein expression and in vitro pull-down assays. E. coli BL21(DE3) were transformed 120 
with pHISTEV-ChlR1 1-130 and 63-214 expression plasmids. Protein expression was induced by 121 
addition of 0.5 mM IPTG to log phase bacterial cultures and incubation at 37 °C for 4 h, in an 122 
orbital shaker. Cell pellets were resuspended in lysis buffer (50mM Na2PO4, pH 6.5, 150mM 123 
NaCl, 1% (w/v) lysozyme, 5mM DTT and protease inhibitor cocktail) and lysed by sonication at 124 
35% amplitude for 2 x 20 s. Lysates were cleared by centrifugation and filtration and added to 125 
50% Ni2+ resin slurry (1 mL lysate/100 µL resin) then incubated for 2 h at 4 °C with agitation. 126 
Unbound lysate was removed and the resin washed three times with 500 µL wash buffer (50 127 
mM Na2PO4, pH 6.5, 150 mM NaCl, 5 mM DTT and protease inhibitor cocktail) and resuspended 128 
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in an equal volume of the same buffer. Purified proteins were assessed by SDS-PAGE and 129 
Coomassie staining.  130 
 131 
Cell culture. C33a cells were maintained in DMEM containing high glucose and L-glutamine, 132 
supplemented with 10% FBS (Sigma). Transfections were carried out with XtremeGene HP 133 
(Roche) at a DNA:reagent ratio of 2:1. Cells were synchronized by double thymidine block and 134 
synchrony confirmed following fixation of cells in 70% ethanol before incubation with 135 
propidium iodide and RNase A and analysis by flow cytometry as previously described (18). For 136 
siRNA-mediated depletion experiments, cells were first transfected with siRNA duplexes by 137 
electroporation using an Amaxa system; 4 x 106 cells were resuspended in 100 µl 138 
electroporation solution (Mirus) and cells were pipetted into a 0.2 cm electroporation cuvette 139 
containing 20 µl of 20 µM ChlR1-specific siRNA targeting the 3’ UTR of ChlR1 (target sequence: 140 
5’-AGUCACUCCUUCAGUAGAAUU-3’) or non-targeting scrambled control (siGENOME Non-141 
targetting siRNA 2, Dharmacon). Cells were electroporated using program S-005 and 142 
immediately plated into a 10cm diameter dish and allowed to recover overnight before 143 
transfection with E2-expressing plasmid DNA using XtremeGene as detailed above.  144 
 145 
Establishment of HPV16 genome-containing human primary keratinocytes and Southern 146 
blotting. The transfection of normal primary human foreskin keratinocytes (HFKs) isolated from 147 
neonatal foreskin epithelia (ethical approval number 06/Q1702/45) was performed in S. 148 
Roberts’ laboratory by J. Parish as previously described (22). To eliminate donor specific effects, 149 
HFKs from two independent donors were used. Following G418 drug selection, cell colonies 150 
were pooled and expanded on terminally gamma-irradiated J2-3T3 fibroblasts in E medium 151 
containing epidermal growth factor. Viral genomes were extracted from each line and 152 
sequenced to ensure appropriate establishment of wild type and mutant genomes. Organotypic 153 
rafts were prepared and cultured for 14 days in E medium without epidermal growth factor as 154 
previously described (22). Southern blotting was performed as previously described (23). 155 
 156 
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In vitro pull-down assays. C33a cells were seeded at a density of 2 x 106 into 10cm tissue 157 
culture dishes and transfected with 2 µg E2 expression plasmid. Cells were lysed 24 h post 158 
transfection in 300 µL IP lysis buffer (17, 18) and 100 µL cleared lysate mixed with equal 159 
amounts of His-ChlR1 1-130 or His-ChlR1 63-214 bound nickel resin in a total reaction volume of 160 
300 µL made up with IP binding buffer (17, 18). Samples were incubated for 16 h at 4 °C. 161 
Unbound lysate was removed and the resin washed three time with 500 µL wash buffer. Bound 162 
proteins were analysed by SDS-PAGE and western blotting.  163 
 164 
Co-immunoprecipitation. C33a cells were transfected and incubated for 24 h. Co-165 
immunoprecipitation experiments were performed as previously described (17, 18) using FLAG-166 
specific antibody (Sigma; M2) or non-specific mouse IgG (Sigma). Co-immunoprecipitated 167 
proteins were separated by SDS-PAGE and detected by western blotting using FLAG and E2-168 
specific antibody TVG261 (Abcam).  169 
 170 
Transcription assay. Transcription assays were performed as previously described (18, 24). 171 
C33a cells (2 x 105) were seeded into each well of a six-well plate and transfected with E2 172 
expression plasmids (100, 250, 500 and 1000 ng) and the luciferase reporter p6E2-tk-Luc (100 173 
ng). Firefly luciferase activity was determined from cell lysates prepared using passive lysis 174 
buffer (Promega) following the addition of Luciferase Assay Reagent (Promega). Protein 175 
expression was confirmed by western blotting. 176 
 177 
Replication assay. Replication assays were performed as described in (24). Briefly, 2.5 x 105 178 
C33a cells were seeded into each well of a 6 well plate. Cells were transfected with 25 ng 179 
pOri16M and expression plasmids for HA-E1 (600 ng) alone or in combination with E2 WT or 180 
Y131A expression plasmids (0.1 ng, 1 ng, 10 ng and 100 ng). Forty-eight hours following 181 
transfection, cells were harvested and DNA extracted using Hirt lysis buffer (0.6% SDS, 10 mM 182 
EDTA). DNA was then purified by phenol/chloroform/isoamyl alcohol extraction followed by 183 
ethanol precipitation and the DNA digested with DpnI. Replicated pOri16M was quantified by 184 
real time PCR as previously described (21). For western blot analysis of exogenous proteins (E1 185 
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and E2), cells transfected in parallel were lysed in urea lysis buffer (50 mM Tris-HCl, pH7.5, 8 M 186 
urea and 14 mM β-mercaptoethanol). Protein concentration was measured by Bradford assay 187 
and 25 µg protein separated by SDS-PAGE before western blotting.  188 
 189 
Sub-cellular fractionation. Forty-eight hours post-transfection, C33a cells were harvested by 190 
trypsinization and counted. 5x106 cells were pelleted and fractionated by sequential lysis using 191 
a subcellular fractionation kit (ThermoScientific). Fractions were analyzed by western blotting 192 
for E2 and proteins used as markers of the cellular fractions (Grb2, cytoplasmic soluble; Orc2, 193 
nuclear soluble; histone H3, chromatin associated; and vimentin, cytoskeletal and nuclear 194 
matrix associated).  195 
 196 
In situ fractionation. C33a cells were seeded into plates containing multiple poly-D-lysine-197 
coated coverslips and transfected with HPV16 E2 WT or Y131A expressing plasmids. Forty-eight 198 
hours post-transfection, coverslips were removed to 6 well plates. Cells were sequentially 199 
extracted to remove cellular fractions as previously described (25). After each step, one 200 
coverslip for each transfection was removed and fixed in 3.7% formaldehyde to allow analysis 201 
of the proteins retained by immunofluorescence staining.  202 
 203 
Immunofluorescence microscopy. Formaldehyde fixed cells were permeabilized by incubation 204 
in 0.2% Triton-X-100 in PBS for 10 min (with the exception of in situ fractionated cells) before 205 
blocking by incubation in 20% heat-inactivated goat serum, 1% BSA in PBS for 1 h at room 206 
temperature (RT). Cells were then incubated in specific primary antibodies diluted in block 207 
solution for 1 h at RT before washing 3 x 5 min in PBS. Cells were then incubated with Alexa-208 
Fluor conjugated secondary antibodies (Invitrogen) diluted 1:1000 in block solution for 1 h at RT 209 
in the dark and washed again 4 x 5 min in PBS. 5 µg/mL Hoechst 33342 in PBS was added to the 210 
final wash to stain DNA. Stained coverslips were mounted in Fluoroshield (Sigma) and cells 211 
were visualized with a Nikon E600 epifluorescent microscope fitted with a DXM1200F digital 212 
camera.  213 
 214 
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Protein stability assay. Protein stability assays were carried out as previously described (34). 215 
Cells were harvested at 0, 2, 4, 8, 12 and 24 h following the addition of 10 µg/mL cycloheximide 216 
(Sigma) and lysed in urea lysis buffer (50 mM Tris-HCl, pH7.5, 8 M urea and 14 mM β-217 
mercaptoethanol). Relative amounts of protein were quantified using Fusion FX digital 218 
chemiluminescence detection system and software and protein half-life was calculated using 219 
Graphpad Prism 4 software using a one-phase exponential decay model.  220 
  221 
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RESULTS 222 
HPV16 E2 associates with ChlR1. Following on from our previous experiments showing that 223 
BPV1 E2 associates with ChlR1 and that mutation of tryptophan 130 to arginine (W130R) 224 
abrogated ChlR1 binding (17), we aimed to determine whether this interaction surface is 225 
conserved in the HPV16 E2 protein. To do this, we established an in vitro binding assay in which 226 
two N-terminal fragments of ChlR1 were cloned and expressed as hexahistidine-tagged fusion 227 
proteins. Since an N-terminal portion of S. cerevisiae Chl1 between amino acids 190-280 was 228 
identified as binding to BPV1 E2 in a yeast two-hybrid screen (17), we predicted that the E2 229 
binding region within human ChlR1 would also exist within the N-terminus of ChlR1. We 230 
therefore expressed and purified amino acids 1-130 and 63-214 of ChlR1 respectively (Figure 231 
1A) and assessed HPV16 E2 binding following incubation of immobilized ChlR1 peptides with 232 
whole cell lysate of HPV16 E2 transfected C33a cells. While HPV16 E2 bound robustly to His-233 
ChlR1 63-214, the E2 protein did not bind to His-ChlR1 1-130 (Figure 1B). This provides evidence 234 
that the E2 binding site within ChlR1 exists between amino acids 130-214 and that HPV16 E2 235 
targets a similar domain of ChlR1 as the BPV1 E2 protein.  236 
To identify the amino acid residues in HPV16 E2 important for association with ChlR1, we 237 
overlaid the crystal structures of the BPV1 and HPV16 E2 proteins (26, 27) and identified amino 238 
acids within HPV16 E2 that are in close physical proximity to BPV1 E2 W130, (17), and that are 239 
surface exposed. Amino acids in HPV16 E2 (herein termed E2) that fit these criteria were 240 
mutated to alanine residues, including glutamic acid 118 (E118), aspartic acid 124 (D124), 241 
tyrosine 131 (Y131), aspartic acid 173 (D173) and lysine 177 (K177). In addition, histidine 130 242 
(H130) was mutated to an arginine as this residue aligns with BPV1 W130 that was previously 243 
mutated to an arginine to abrogate ChlR1 binding (17) (Figure 2A). Mutation was confirmed by 244 
sequencing and the effect on ChlR1 binding determined using the in vitro pull-down assay 245 
described above (Figure 2B and Table 1). With the exception of E2E118A, which bound ChlR1 to 246 
similar levels as E2WT, most of the point mutations created on the ChlR1 binding surface of E2 247 
reduced binding to ChlR1 in comparison to the E2WT protein. Notably, the mutant E2Y131A was 248 
severely impaired in its ability to bind ChlR1. On average E2Y131A protein had an 18-fold 249 
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reduction in ChlR1 binding in comparison to E2WT protein between multiple experiments, and 250 
this reduction in binding was consistent.  251 
To determine whether E2Y131A was also unable to bind to ChlR1 in cells, co-immunoprecipitation 252 
experiments were performed. C33a cells were co-transfected with FLAG-ChlR1 and E2WT or 253 
E2Y131A expression plasmids, and lysates immunoprecipitated with FLAG-specific antibody or 254 
non-specific IgG control antisera.  As expected, E2WT was robustly co-immunoprecipitated with 255 
FLAG-ChlR1 but E2Y131A was severely reduced in ChlR1 binding (Figure 2C). Together, these data 256 
show that HPV16 E2 associates with ChlR1 and that tyrosine 131 is essential for efficient ChlR1 257 
binding.  258 
 259 
Mutation of Y131 within the E2 transactivation domain does not affect the transcription 260 
activation or origin-dependent replication functions of E2. The E2 protein is an important 261 
regulator of HPV early gene transcription and recruits the viral E1 helicase to the origin of 262 
replication (Ori) to initiate virus replication. These functions of E2 are essential for the virus life 263 
cycle. To determine whether E2Y131A is able to support these viral functions and therefore 264 
whether interaction with ChlR1 plays a role in E2-dependent virus transcription and replication, 265 
we first utilized a synthetic transcription reporter that has been previously been shown to be 266 
responsive to E2 expression in a dose-dependent manner (16). Cells were co-transfected with 267 
increasing amounts of E2WT or E2Y131A expressing plasmids. Luciferase activity and 268 
corresponding E2 protein expression were determined in whole cell lysates (Figure 3A and B). 269 
E2Y131A consistently activated transcription to similar levels as E2WT, demonstrating that 270 
mutation of Y131 and loss of ChlR1 interaction does not affect the transcriptional activation 271 
function of the E2 protein.  272 
To determine whether E2Y131A is able to activate virus replication to levels comparable to E2WT, 273 
cells were transfected with a plasmid containing the HPV16 origin of replication (pOri16M), HA-274 
tagged HPV16 E1 and increasing amounts of either E2WT or E2Y131A proteins. Co-transfection of 275 
cells with E2WT or E2Y131A and HA-E1 resulted in an E2 dose-dependent activation of Ori-276 
dependent replication above that observed with either Ori alone or Ori co-transfected with 277 
either HA-E1 or E2 alone. Notably, there were no significant differences in the ability of E2WT 278 
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and E2Y131A to activate origin-dependent replication, confirming that E2Y131A is capable of 279 
activating virus replication and is as active as E2WT in this assay (Figure 3C and D).  280 
 281 
Loss of ChlR1 binding results in enhanced nuclear matrix association of E2. Analysis of the E2 282 
protein expression levels in the transcription assay described above suggested that E2Y131A 283 
protein was expressed at lower levels than wild type E2 (Figure 3B). However this reduction in 284 
E2Y131A expression in comparison to E2WT was not observed in the replication assays (Figure 3D). 285 
This apparent difference could be explained by the different methods used to prepare cell 286 
lysates in these two experiments. The protein lysates in the transcription assays were prepared 287 
using a proprietary passive lysis buffer (Promega), optimized for luciferase-based assays and 288 
therefore extracts only soluble cellular proteins. In contrast, the lysates for the replication assay 289 
were prepared with urea lysis buffer which extracts all cellular proteins including chromatin 290 
bound and insoluble proteins. We therefore directly compared the amount of E2WT and E2Y131A 291 
proteins extracted with these two different buffers. While, the amount of E2WT extracted with 292 
urea lysis buffer was similar to that extracted with passive lysis buffer, the amount of E2Y131A 293 
extracted with urea lysis buffer was consistently greater than that extracted with passive lysis 294 
buffer. Over three-fold more E2Y131A was extracted with the urea buffer than the passive lysis 295 
buffer, while no significant differences were observed with E2WT (Figure 4A). These data suggest 296 
that E2Y131A is expressed at similar levels as E2WT, but is less soluble. The difference in solubility 297 
may be due to altered association with cellular structures such as chromatin or the nuclear 298 
matrix. Therefore, the sub-cellular localization of E2Y131A in comparison to E2WT was also 299 
determined by immunofluorescent staining. In C33a cells, E2WT protein was predominantly 300 
localized in the nuclear compartment with some cytoplasmic staining visible, as previously 301 
reported in formaldehyde fixed cells (18). While E2Y131A was also predominantly localized in the 302 
nuclear compartment, there was a clear increase in cytoplasmic staining (Figure 4B). This was 303 
somewhat surprising because the Y131A mutation is not within the known nuclear localization 304 
signals in E2 (28).  305 
To analyze further the differences in sub-cellular localization between E2WT and E2Y131A, 306 
transfected C33a cells were fractionated into soluble cytoplasmic, membrane-associated, 307 
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soluble nuclear, chromatin bound and cytoskeletal/nuclear matrix fractions and the presence of 308 
E2 in each fraction determined by western blotting (Figure 4C). Quantification of these 309 
experiments revealed that there was no significant change in the level of E2Y131A in the 310 
cytoplasmic or membrane fractions compared to the E2WT protein. However, there was a 311 
significant reduction in the soluble nuclear fraction of E2Y131A in comparison to the E2WT protein 312 
(p < 0.05) and a concomitant increase in the proportion of E2Y131A protein associated with the 313 
cytoskeletal and nuclear matrix fraction (p < 0.001) (Figure 4D).  314 
Previous studies demonstrated that the association of BPV1 E2 with ChlR1 predominantly 315 
occurs in mid-S phase when cellular DNA replication takes place (18). We therefore sought to 316 
determine the cell cycle dependence of the differences in E2WT and E2Y131A sub-cellular 317 
localization. E2 expressing C33a cells were synchronized at the G1/S boundary or in mid-S 318 
phase (Figure 5A) and fractionated as described in Figure 4. While, the subcellular localization 319 
of E2WT was not significantly altered in G1/S or in mid-S phase enriched populations of cells, 320 
there was a significant difference in the sub-cellular localization of E2Y131A (Figure 5B). As cells 321 
progressed to mid-S phase, the amount of nuclear soluble E2Y131A was reduced by two-fold (p < 322 
0.05) whereas the amount of cytoskeletal and nuclear matrix associated E2Y131A protein was 323 
increased two-fold (p < 0.05), in comparison to that observed in the G1/S synchronized cells. 324 
These data indicate that the interaction between E2 and ChlR1 is important for the solubility of 325 
E2 and that loss of ChlR1 binding increases the less soluble, cytoskeletal and/or nuclear matrix-326 
associated pool of E2 protein specifically during S-phase. 327 
It is important to note that the fractionation experiments described thus far were performed 328 
using a biochemical fractionation method that does not distinguish between cytoskeletal- and 329 
nuclear matrix-associated proteins. Therefore, to fully characterize the effect of reduced ChlR1 330 
binding on the sub-cellular localization of the E2 protein and to specifically analyze nuclear 331 
matrix attachment of E2Y131A in comparison to E2WT, cells were in situ fractionated to visualize 332 
individual cells after sequential removal of cytoplasmic, soluble nuclear and chromatin bound 333 
proteins. C33a cells growing on multiple coverslips in a single tissue dish were transfected with 334 
either E2WT or E2Y131A expression plasmids. In situ fractionation was performed and the 335 
proportion of E2 positive cells at each fractionation step was analyzed by immunofluorescent 336 
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staining of E2 protein and normalized to the transfection efficiency calculated in the whole cell 337 
sample. DNA and lamin B1 protein staining was also performed in each fraction to demonstrate 338 
loss of chromatin following DNaseI treatment and retention of nuclear matrix in the final 339 
fractionation step (Figure 6A).  Removal of cytoplasmic proteins revealed no significant 340 
difference in the number of cells with nuclear E2WT or E2Y131A proteins. However, removal of 341 
soluble nuclear proteins, leaving chromatin bound and nuclear matrix associated proteins 342 
revealed a small but significant increase in the proportion of cells positive for E2Y131A compared 343 
the E2WT protein (p < 0.05). This difference was sustained but increased in magnitude upon 344 
removal of cellular chromatin by treatment of the cells with DNaseI, leaving only nuclear matrix 345 
associated proteins. The proportion of cells that retained nuclear matrix associated E2 was 2.8 346 
fold greater in E2Y131A transfected cells than in E2WT transfected cells (p < 0.01). These data 347 
suggest that the ChlR1-binding defective E2Y131A protein is less tightly associated with cellular 348 
chromatin, and more tightly associated with the nuclear matrix than the E2WT protein.   349 
To strengthen our conclusion that loss of ChlR1 binding results in a significant change in the 350 
solubility of nuclear E2 protein, endogenous ChlR1 protein was depleted by RNA interference in 351 
E2WT expressing C33a cells. Cells were transfected with ChlR1-specific and non-targeting siRNA 352 
duplexes and the reduction in ChlR1 protein expression confirmed by western blot analysis 353 
(Figure 6C). In situ fractionation of cells was performed as described in Figure 6A. There was no 354 
significant difference in the proportion of E2 expressing cells following removal of cytoplasmic 355 
and nuclear soluble proteins in comparison to control siRNA transfected cells. However, 356 
subsequent removal of chromatin bound proteins by DNaseI treatment revealed a significant 357 
increase in nuclear matrix association of E2WT in the ChlR1-depleted cells in comparison to 358 
control siRNA transfected cells (Figure 6D). Together, these data indicate that disruption of the 359 
association with ChlR1, either by mutation of E2 to prevent ChlR1 binding or by siRNA-mediated 360 
depletion of ChlR1, leads to a change in solubility of the nuclear pool of E2. Loss of ChlR1 361 
binding causes decreased chromatin association of E2, likely to be important for viral genome 362 
tethering, and increased nuclear matrix attachment.  363 
 364 
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Reduced ChlR1 binding increases E2 protein stability. It has previously been shown that 365 
overexpression of the C-terminal domain of Brd4, which contains the E2 binding domain, 366 
dramatically increases E2 protein stability by blocking ubiquitylation of E2 by the cullin-3 E3 367 
ligase complex (29). In addition, interaction of E2 with TaxBP1, a component of the cullin-3 368 
complex inhibits proteasome-mediated degradation of E2 (30). This regulation of E2 protein 369 
stability is not limited to interacting cellular proteins; interaction with the E1 viral helicase and 370 
the intermediate-late protein E1^E4 also increases E2 protein stability (31, 32), although the 371 
mechanism of E1 and E1^E4-mediated E2 stabilization is not clear. In light of our data showing 372 
that ChlR1 interaction regulates the chromatin- and nuclear matrix-associated cellular pools of 373 
E2, we hypothesized that ChlR1 interaction also plays a role in regulating E2 protein stability, 374 
since attachment of E2 to cellular structures such as the nuclear matrix might inhibit 375 
proteasome-mediated degradation. Therefore, to determine whether E2Y131A protein has 376 
altered stability in comparison of E2WT, C33a cells transfected with either E2WT or E2Y131A were 377 
treated with cycloheximide to inhibit protein synthesis and E2 protein half-life determined by 378 
analysis of E2 protein levels by western blotting at increasing time intervals (Figure 7). 379 
Surprisingly, these experiments revealed a consistent and dramatic increase in half-life of 380 
E2Y131A compared to E2WT from 4 h (E2WT) to 44 h (E2Y131A), even though an increase in the 381 
steady-state expression levels of E2WT and E2Y131A were comparable (Figure 7, 0 hours). This 382 
increase in protein stability without a noticeable difference in protein expression levels could 383 
be due to the high levels of protein production in these transient transfection assays, which 384 
may mask differences in protein stability unless the continued production of protein is inhibited 385 
by treatment with cycloheximide. Nonetheless, our data clearly show increased stability of 386 
E2Y131A in comparison to E2WT when cells are treated with cycloheximide. 387 
Association of HPV16 E2 with ChlR1 is required for high copy number viral genome 388 
establishment and episome persistence. To determine the biological significance of the 389 
interaction between E2 and ChlR1 in the HPV16 life cycle, the Y131A mutation was introduced 390 
into the E2 open reading frame of the HPV16 genome and recircularized viral genomes 391 
transfected into primary foreskin keratinocytes harvested from two independent donors. 392 
Following selection of transfected cells, and the establishment and expansion of cell 393 
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populations, total HFK DNA was harvested at subsequent early passages for analysis by 394 
Southern blotting (Figure 8). Digestion of DNA with HindIII, a non-cutter of the HPV16 genome 395 
revealed the presence of episomes in the wild type genome containing cells at all three 396 
passages examined, but episomes were barely detectable in those cells harboring the E2Y131A 397 
mutant genomes. Linearization using BamHI showed that the wild type episomes were present 398 
at approximately 50 copies per cell at passage 1 with maintenance of episomes at a slightly 399 
lower copy number at passage 2 and 5. In the mutant genome containing cells, the linearized 400 
genomes were present at approximately 5 copies per cells in the early passage but were not 401 
detectable at passage 5, indicating episomal loss. These observations were consistent between 402 
the 2 two donor lines.    403 
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DISCUSSION 404 
Our findings provide novel insight into the role of ChlR1 in the HPV16 life cycle. We show for 405 
the first time that HPV16 E2 associates with ChlR1 and, as has previously been shown for BPV1 406 
E2 (17), that the binding site for HPV16 E2 exists in the N-terminal region of ChlR1, between the 407 
highly conserved I and Ia helicase motifs. It is interesting to note that this region of ChlR1 is 408 
unique amongst related iron-sulfur cluster proteins (33), suggesting that the E2 protein has 409 
evolved to specifically target ChlR1 and not related family members such as FANCJ and XPD. 410 
Identification of a single amino acid mutation at tyrosine 131 in E2 that severely impairs ChlR1 411 
binding, but does not affect the transactivation or replication activities of E2, has allowed us to 412 
dissect the role of ChlR1 in E2 function. We show that E2Y131A has a significantly enhanced half-413 
life and is less soluble than E2WT proving evidence that ChlR1 binding maintains a pool of E2 in 414 
the soluble protein fraction, which negatively affects E2 protein stability. Since functional 415 
assays demonstrate that the E2Y131A mutant protein is able to support transcription activation 416 
and virus replication, they provide evidence that introduction of this specific mutation does not 417 
result in mis-folded E2 that precipitates within the cell. We therefore conclude that the stability 418 
and solubility of E2 regulated by interaction with ChlR1 is of biological importance. 419 
Several studies have identified binding partners of E2 that regulate the stability or solubility of 420 
this essential HPV protein. Interaction with cellular proteins Brd4 and Tax1BP1 has been shown 421 
to stabilize E2 through inhibition of the proteasome-mediated protein degradation pathway 422 
(29, 30). It has been demonstrated that interaction of HPV16 E2 with its viral binding partner, 423 
E1 increases the stability of E2 and increases the affinity of E2 for cellular chromatin (32) and 424 
that interaction with E1^E4 also increases E2 protein stability (31). Interaction with TopBP1 has 425 
been shown to regulate the solubility of E2 but, in contrast to our findings, without affecting 426 
the stability of E2 (15). As with loss of ChlR1 binding, Donaldson et al showed that depletion of 427 
TopBP1 resulted in an increase in insoluble E2, which the authors suggest is due to an increase 428 
in chromatin association. However, these experiments did not specifically distinguish between 429 
chromatin bound proteins and nuclear matrix associated proteins, making it difficult to 430 
conclude that the less soluble fraction of E2 protein was specifically chromatin bound rather 431 
than tightly associated with the nuclear matrix. Nonetheless, the parallels between ChlR1- and 432 
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TopBP1-binding defective E2 proteins are interesting and may suggest that distinct cellular 433 
pools of E2 are bound by these proteins to regulate E2 solubility and activity at distinct stages 434 
of the cell cycle and/or virus life cycle.  435 
The genomes of several HPV types, including HPV16, have been shown to bind with high affinity 436 
to the nuclear matrix (34). It has also been shown that the majority of HPV11 E2 protein is 437 
tightly associated with the nuclear matrix of transfected cells and that very little cytoplasmic or 438 
chromatin bound protein exists in these cells (35). However, the steady state distribution of 439 
HPV16 E2 is somewhat different; our findings show that only around 30% of the cellular pool of 440 
HPV16 E2WT is nuclear matrix associated, while the rest of the protein is distributed throughout 441 
the chromatin bound, soluble nuclear and cytoplasmic compartments of transfected cells. 442 
Interestingly, it was shown that a conserved patch of basic amino acids within the hinge region 443 
of HPV11 E2 is essential for strong attachment to the nuclear matrix (35). Mutation of this 444 
patch of basic amino acids in HPV11 E2 to alanine residues resulted in an increase in 445 
cytoplasmic E2 localization. Also, there was a loss of nuclear E2 foci, which are thought to be 446 
important for HPV DNA replication. It was suggested from these studies that the nuclear matrix 447 
provides a structural scaffold for E2 compartmentalization and that attachment to the nuclear 448 
matrix is important for viral DNA replication and viral mRNA transcription. Our findings suggest 449 
that the regulation of nuclear distribution of the HPV16 E2 protein is more complex and that 450 
ChlR1 binding solubilizes a pool of E2 by reducing nuclear matrix association. However, it is 451 
important to note that the differences in sub-cellular localization of E2WT and E2Y131A when 452 
over-expressed in human keratinocytes may not accurately reflect the localization of these 453 
proteins when they are expressed at low levels from the viral genome and although interaction 454 
with ChlR1 regulates the subcellular distribution of E2, our previous studies suggest that E2 455 
expression does not affect the gross localization of ChlR1 (17, 19). Nonetheless, loss of ChlR1 456 
association not only increases the association of E2 with the nuclear matrix, but also increases 457 
the cytoplasmic pool of E2. Whether this increase in cytoplasmic E2 is due to increased protein 458 
stability or loss of retention in the nucleus is not clear but our data show that the ability of 459 
ChlR1 to regulate subcellular pools of E2 is essential for viral episome maintenance, consistent 460 
with our previous findings in BPV1.  461 
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Our previous studies have shown that ChlR1 is important for sister chromatid cohesion 462 
establishment and thus supports high fidelity chromosome segregation during mitosis (19). It 463 
has since been demonstrated that ChlR1 is important for heterochromatin organization and 464 
that depletion causes decreased chromatin compaction at pericentric and telomeric 465 
chromosomal regions (36). Furthermore, in vitro assays show that ChlR1 helicase efficiently 466 
unwinds DNA structures that contain G-quadruplex (G4) structures (37), which are frequently 467 
found in heterochromatin (38). This ability to resolve G4 structures that inevitably stall 468 
replication forks may help to explain why ChlR1 deficient cells are highly sensitive to DNA 469 
crosslinking agents, such as cisplatin and mitomycin C, that stall the replication machinery (39). 470 
In yeast, the ChlR1 homologue, Chl1, genetically interacts with the alternative replication factor 471 
C complex protein RFC-Ctf18, which is involved in sister chromatid cohesion establishment and 472 
replication fork stabilization (40). In addition, ChlR1 is known to associate with replication fork 473 
proteins such as proliferating cell nuclear antigen (PCNA) and the flap endonuclease, Fen1 (41, 474 
42), and is important for replication recovery following DNA damage (43). Given these roles in 475 
replication fork stability and replication-coupled DNA damage resolution, the association 476 
between the HPV E2 protein and ChlR1 could conceivably result in recruitment of E2 to stalled 477 
replication complexes, although it should be noted that we have not demonstrated that E2 478 
directly binds ChlR1. Nonetheless, our data show that loss of ChlR1 binding results in reduced 479 
nuclear matrix association of E2 and increased solubility. Indeed, we have previously shown 480 
that BPV1 E2 specifically targets ChlR1 during active DNA replication at S-phase (18), which 481 
likely explains why the shift in soluble nuclear E2 to insoluble nuclear matrix-associated E2 482 
following abrogation of ChlR1 binding is significant in cells synchronized in S phase and not in 483 
cells synchronized at the G1/S boundary. Put together, our data suggest that E2 targets ChlR1 484 
during DNA replication to allow positioning of the E2-HPV genome complex at the replication 485 
fork when ChlR1 is recruited at difficult to replicate sites. This reduces the nuclear matrix 486 
association of the E2 protein and facilitates loading of the viral genomes to cellular chromatin 487 
prior to mitotic segregation.  This mechanism of E2-HPV genome attachment to cellular 488 
chromatin is essential for the establishment and persistence of high copy HPV episomes. 489 
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FIGURE LEGENDS 496 
 497 
Figure 1. HPV16 E2 associates with the N-terminus of ChlR1. (A) His-tagged ChlR1 peptides 1-498 
130 and 63-214, indicated by *, were expressed and purified from E.coli and eluted from nickel 499 
affinity resin in fractions designated 1, 2 and 3. (B) Western analysis of His-ChlR1 pull down 500 
assays of E2 protein expressed in C33a cells lysates (input shown on the left). E2 associates with 501 
His-ChlR1 63-214 but not with His-ChlR1 1-130. Molecular weight markers (kDa) are indicated 502 
on the left of each panel.  503 
 504 
Figure 2. Isolation of a ChlR1-binding defective mutant of HPV16 E2. (A) Overlay of the N-505 
terminal transactivation domains of BPV1 E2 (black) and HPV16 E2 (purple) produced in Pymol. 506 
Residue W130 in BPV1 E2 is highlighted in green. The pink residues shown are surface exposed 507 
residues that are situated on the same surface of HPV16 E2 as W130 in BPV1 E2 that were 508 
mutated to alanine or arginine as described in Table 1. (B) Binding of HPV16 E2 mutants to His-509 
ChlR1 63-214 was analyzed in comparison to E2WT. A representative experiment is shown and a 510 
summary of all results is given in Table 1. (C) C33a cells growing in 10cm dishes were 511 
transfected with 2 μg FLAG-ChlR1 and E2WT or E2Y131A expression plasmids. Inputs for co-512 
immunoprecipitation reactions are shown in the left panel. Lysates were immunoprecipitated 513 
with FLAG or non-specific IgG as described (right panels). Image is representative of three 514 
independent and consistent repeats.  515 
 516 
Figure 3. HPV16 E2Y131A is transcription and replication competent. (A) C33a cells were 517 
transfected with an E2-dependent luciferase reporter (p6E2-tk-Luc) alone or in combination 518 
with increasing amounts of E2WT or E2Y131A expressing plasmids. Data show mean luciferase 519 
activity and standard error of three independent experiments. (B) E2 protein expression was 520 
determined by western blotting in comparison to β-actin loading control. (C) C33a cells were 521 
transfected with pOri16M, which contains to HPV16 origin of replication alone or in 522 
combination with HPV16 E1 only, E2 only or a combination of E1 (constant) and E2 (0.1, 1, 10 523 
and 100 ng) expression plasmids. Replication was assessed by real time PCR of DpnI digested 524 
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DNA. Experiments were performed in triplicate and data show the mean and standard 525 
deviation of intra-experimental repeats and are representative of three independent 526 
repetitions. (D) HPV16 HA-E1 and E2 protein expression was determined by western blotting 527 
and compared to β-actin loading control. 528 
 529 
Figure 4. HPV16 E2Y131A associates with the nuclear matrix and cellular cytoskeleton with 530 
higher affinity that E2WT. (A) C33a cells were transfected with 100ng (+) or 200ng (++) E2WT or 531 
E2Y131A expression plasmids and lysed with either passive lysis buffer to extract soluble proteins 532 
or urea lysis buffer to extract all cellular proteins. Western blots of three independent 533 
repetitions were analyzed by densitometry and the fold change in E2 protein in comparison to 534 
loading control calculated. (B) C33a cells growing on coverslips in 6 well dishes were 535 
transfected with 1 μg E2WT or E2Y131A expression plasmids and E2 protein (green) localization 536 
assessed by immunofluorescent staining. DNA (blue) was stained with Hoescht 33342. Scale bar 537 
indicates 10μm. (C) C33a cells growing in 10 cm dishes were transfected with 2 μg E2 538 
expression plasmid (E2WT or E2Y131A) were fractionated to give cytoplasmic soluble (C), 539 
membrane associated (M), soluble nuclear (N), chromatin bound (CB) and cytoskeletal/nuclear 540 
matrix associated (CN) fractions. Fractions were analyzed by western blotting to determine the 541 
sub-cellular localization of E2WT and E2Y131A as compared to reference proteins Grb2 542 
(cytoplasmic and membrane associated), Orc2 (soluble nuclear), Histone 3 (chromatin bound) 543 
and Vimentin (cytoskeletal). (D) The percentage of E2 protein in each protein fraction was 544 
determined by densitometry of three independent experimental repeats and shown as the 545 
mean and standard error of the mean. *p<0.05, ***p<0.001.  546 
 547 
Figure 5. Altered sub-cellular localization of E2Y131A in comparison to E2WT is S phase specific. 548 
(A) C33a cells growing in 10 cm dishes were were transfected with 2 μg E2WT or E2Y131A 549 
expression plasmids and synchronized by double thymidine block. Cells were then either 550 
harvested (G1/S) or released for 3 hours (mid-S phase) before staining with propidium iodide 551 
(PI). Cell cycle distribution was determined by flow cytometry of over 20,000 cells. (B) 552 
Synchronized cell populations were fractionated as described in Figure 4 and E2 distribution 553 
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determined by western blotting alongside markers of sub-cellular fraction. The percentage of 554 
E2 protein (E2WT or E2Y131A) in each fraction was determined by densitometry of three 555 
independent experiments and shown as the mean and standard deviation of total E2 protein. 556 
n.s.; not significant, *p < 0.05.  557 
 558 
Figure 6. HPV16 E2Y131A has reduced chromatin association and increased nuclear matrix 559 
association. (A) C33a cells growing on coverslips were transfected with 1 μg E2WT or E2Y131A 560 
expressing plasmids and fixed with paraformaldehyde to observe whole cell localization, or in 561 
situ fractionated as described in the materials and methods to sequentially remove cytoplasmic 562 
proteins (leaving nuclear proteins), nuclear soluble proteins (leaving chromatin bound and 563 
nuclear matrix associated proteins) and chromatin bound proteins (leaving nuclear matrix 564 
associated proteins only). E2 protein (green) and Lamin B1 (red) in each fraction was visualized 565 
by immunofluorescent staining and the DNA (blue) stained with Hoescht 33342. Scale bar 566 
indicates 10μm. (B) The percentage of E2 positive cells in each fraction in comparison to fixed 567 
whole cells was determined for E2WT or E2Y131A transfected populations. The data shown are the 568 
mean and standard error of three independent repeats. *p<0.05, **p<0.01.  (C) C33a cells were 569 
transfected with ChlR1-specific of control siRNA duplexes as described in the methods and 570 
ChlR1 depletion determined by western blotting. (D) ChlR1 and control siRNA transfected cells 571 
were in situ fractionated as described in (A) and the percentage of E2WT positive cells in 572 
comparison to fixed whole cells after each fractionation step determined by 573 
immunofluorescent staining. The data show the mean and standard deviation of three 574 
independent experiments. *p<0.05.  575 
 576 
Figure 7. HPV16 E2Y131A displays enhanced protein stability in comparison to E2WT. (A) C33a 577 
cells were transfected with 2 μg E2WT or E2Y131A expression plasmids. Twenty-four hours 578 
following transfection, cells were seeded into 6 well dishes and treated with cycloheximide as 579 
described in the materials and methods. Cells were harvested at the stated time points, lysed in 580 
urea lysis buffer and E2 protein levels determined by western blotting. (B) Relative E2 protein 581 
levels were normalized to β-actin loading control at each time point following densitometric 582 
Harris et al.                                                                    ChlR1 regulates the chromatin association of HPV16 E2 
 28
analysis of digitally imaged western blots. Data shows the mean and standard deviation three 583 
independent experimental repeats.  584 
 585 
Figure 8. Transcription and replication competent HPV16 E2Y131A does not support viral 586 
genome establishment and maintenance in primary human keratinocytes. Primary human 587 
foreskin keratinocytes were transfected with recircularized wild type HPV16 genomes or HPV16 588 
genomes encoding E2Y131A. Cells were harvested at passages 1, 2 and 5 and DNA extracted for 589 
Southern blot analysis following restriction enzyme digestion with DpnI and either HindIII that 590 
does not cut the viral genomes or BamHI that linearizes the viral episomes.  Copy number 591 
controls equivalent to 500, 50 and 5 viral copies per cell are shown on the left.  592 
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TABLES 593 
 594 
 595 
Residue(s) mutated % E2 bound* 
E118A 106.69 
D124A 38.78 
H130R 45.23 
Y131A 5.43 
D173A 80.51 
K177A 36.34 
   596 
Table 1: Analysis of ChlR1 binding of HPV16 E2 mutants in comparison to E2WT. C33a cells 597 
were transfected with E2WT or mutant E2 expression plasmids and cell lysates incubated with 598 
His-ChlR1 63-214 protein immobilized on nickel resin as described in Figure 2. Bound E2 protein 599 
was determined by western blotting and compared to input by densitometric analysis of digital 600 
images. Percentage of E2 mutant protein bound to His-ChlR1 63-214 was calculated in 601 
comparison to E2WT binding. The data are the mean of at least two independent experiments.  602 








